Showing 1791-1800 of 2657 results for "".
- Schwind Introduces WiseNET Intelligent Web-Based Databasehttps://modernod.com/news/schwind-introduces-wisenet-intelligent-web-based-database/2476554/Schwind WiseNET is a web-based database that allows the user to capture and evaluate refractive treatment data quickly and precisely, and present it graphically for all sorts of uses in daily clinical work. Diagrams s
- Oertli Upgrades its Faros Compact Surgical Platformhttps://modernod.com/news/oertli-upgrades-its-faros-compact-surgical-platform/2476470/Swiss manufacturer Oertli Instrumente has upgraded its compact surgical platform Faros with new features to make the surgeon’s work easier, safer, and more efficient, according to a company
- Quantel Medical Receives FDA Approval for ABSolu Ultrasound Platformhttps://modernod.com/news/quantel-medical-receives-fda-approval-for-absolu-ultrasound-platform/2476415/Quantel Medical announced that it has received approval from the FDA for the new A/B/S ultrasound platform: ABSolu. The ABSolu includes a new 5 ring annular technology 20MHz B probe that increases the depth of
- Nicox Signs Agreement for Zerviate in China for Up to €17 Million in Milestone Payments Plus Royaltieshttps://modernod.com/news/nicox-signs-agreement-for-zerviate-in-china-for-up-to-e17-million-in-milestone-payments-plus-royalties/2476381/Nicox SA and Ocumension Therapeutics announced they have entered into an exclusive license agreement for the development and commercialization of Nicox’s product Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of all
- New Medscape Report Finds More Than One in Three Doctors are Burned Outhttps://modernod.com/news/new-medscape-report-finds-more-than-one-in-three-doctors-are-burned-out/2476292/Burnout and depression are having a significant effect on the global medical community, as demonstrated by Medscape’s Global Physicians’ Burnout and Lifestyle Comparisons report. Nearly 20,000 doctors in six countries (France,
- Nicox Announces FDA Acceptance of Investigational NDA for NCX 4251 Phase 2 Trial in Blepharitishttps://modernod.com/news/nicox-announces-fda-acceptance-of-investigational-nda-for-ncx-4251-phase-2-trial-in-blepharitis/2479597/Nicox SA announced that the FDA has completed its review of the company’s investigational new drug (IND) application for NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals, being developed as the fi
- EMA Handed Down Fewer Positive Drug Opinions in 2018https://modernod.com/news/ema-handed-down-fewer-positive-drug-opinions-in-2018/2476203/In 2018, the European Medicines Agency (EMA) recommended marketing authorization for 84 new medicines, down from 92 in 2017, according to a report in Medscape. The 84 medicines given a thumbs up by EMA’s Committee for Medicin
- Nicox and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize NCX 470 in the Chinese Markethttps://modernod.com/news/nicox-and-ocumension-therapeutics-sign-exclusive-license-agreement-to-develop-and-commercialize-ncx-470-in-the-chinese-market/2479610/Nicox and Ocumension Therapeutics announced they have entered into an exclusive license agreement for the development and commercialization of Nicox’s product candidate, NCX 470, targeting patients with glaucoma or ocular hypertension
- Verily, Alcon, Halt Project to Create a Glucose-Measuring Contact Lens; Other Eye-Monitoring Projects Continuehttps://modernod.com/news/verily-alcon-halt-work-on-glucose-sensing-smart-contact-lens/2479656/Google’s life sciences company Verily and Alcon have decided to halt their work on a smart contact lens to measure glucose levels in users with diabetes. In a blog post, Verily chief technical o
- U.S. Appeals Court Rules Against Allergan Over Validity of Restasis Patentshttps://modernod.com/news/u-s-appeals-court-rules-against-allergan-over-validity-of-restasis-patents/2479660/Allergan’s patents on its blockbuster eye drug Restasis are invalid, a U.S. appeals court ruled, according to a Bloomberg report. Without issuing a formal opinion, the U.